This alludes to a model whereby activation of IGF1R/AKT axis promotes survival of cancer cells with complex IV dysfunction by driving glycolysis, while concomitant suppression of mTOR is required to decrease energy consumption and thus compensate for disrupted mitochondrial ATP production. This evidence concerns the gene IGF1R and cancer.